Financial statements Medicofarma Biotech
Cash flow statement of Medicofarma Biotech
Company age:
Age:
17 y. 2 m. 7 d.
Share capital:
Share capital:
500 000 PLN
Cash inflows of MEDICOFARMA BIOTECH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -17 469,88 | -380 857,48 | -311 734,64 | 1 815 662,80 | 960 269,55 | 7 256,26 |
| Net cash flow from investing activities | 0,00 | -139 999,00 | 342 149,95 | -16 011 386,36 | -1 208 126,21 | -1 106 280,23 |
| Net cash flow from financial activities | 9 971,10 | 227 156,81 | -66 264,37 | 14 249 094,84 | 678 101,00 | 596 700,00 |
| Total net cash flow | -7 498,78 | -293 699,67 | -35 849,06 | 53 371,28 | 430 244,34 | -502 323,97 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.